Lazard Asset Management
ATRS

Lazard Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Lazard Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,567
Closed -$84K – 2650
2022
Q1 		$84K Buy
20,567
+3,831
+23% +$13.9K ﹤0.01% 1483
2021
Q4 		$59K Buy
16,736
+9,580
+134% +$33.5K ﹤0.01% 1666
2021
Q3 		$26K Buy
+7,156
New +$28.9K ﹤0.01% 1959
2021
Q2 		– Sell
-15,178
Closed -$62K – 2138
2021
Q1 		$62K Buy
15,178
+1,265
+9% +$5.48K ﹤0.01% 1357
2020
Q4 		$55K Sell
13,913
-6,649
-32% -$21.5K ﹤0.01% 1357
2020
Q3 		$55K Sell
20,562
-1,397
-6% -$3.87K ﹤0.01% 1162
2020
Q2 		$60K Buy
21,959
+4,213
+24% +$11.8K ﹤0.01% 1182
2020
Q1 		$41K Buy
17,746
+8,235
+87% +$28K ﹤0.01% 1264
2019
Q4 		$44K Buy
9,511
+5,337
+128% +$21.8K ﹤0.01% 1088
2019
Q3 		$13K Buy
+4,174
New +$13.7K ﹤0.01% 1244

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lazard Asset Management's ATRS Position: Q2 2022 in Review

Lazard Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 20,567 shares — an estimated $84K sold.

Lazard Asset Management first reported a position in ATRS in Q3 2019 and held it in 10 quarters. The position peaked at $84K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Lazard Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Lazard Asset Management sold 20,567 Antares Pharma, Inc. shares in Q2 2022, an estimated $84K.
  • Lazard Asset Management first reported a position in Antares Pharma, Inc. in Q3 2019 and held it in 10 quarters.
  • Lazard Asset Management's Antares Pharma, Inc. position peaked at $84K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Lazard Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.